Library

Filter

2019 is the year of the fight against thrombocytopenia

In 2019, «Yuria-Pharm» announced the year for the fight against thrombocytopenia. Regarding this company, an appropriate program was started, in which cancer and hematologic departments throughout Ukraine received recombinant human thrombopoietin (EMAPLUG) as charitable aid for patients with thrombocytopenia. Many readers of the medical newspaper “News of Medicine and Pharmacy” ...

The possibilities of using combination therapy in patients with dyscirculatory encephalopathy

Abstract.The article presents the results of a clinical study on the efficiency and tolerability of the combined use of drugs Neurocytin and Latren, solutions in comparison with the drug Neurocytin, solution, produced by Yuria Pharm Ltd. in patients with stage II arterial hypertension (AH) and atherosclerosis. Studies were conducted in ...

Treatment of Recombinant Human Thrombopoietin in Thrombocytopenia after Chemotherapy of Acute Leukemia

After chemotherapy, the patients with acute leukemia often accompany with severe thrombocytopenia, and it is difficult to be prevented and treated. For a long time, platelet transfusion is always the standard therapeutic method for severe thrombocytopenia with definite efficacy. But the platelets have short storage time, nervous sources, and can ...

Japanese Guidelines for the Management of Stroke 2015 [2017]. Section 1.10. Medical therapy, aimed at the brain protection.

Recommendations: Edaravon, a drug with an expected neuroprotective effect, recommended as a medicine for patients with cerebral ischemic stroke (thromboembolism) (grade B). Key words: edaravon; acute ischemic stroke.

Balanced solutions in infusion therapy for acute pancreatitis: practice-proven efficacy

To view the article, click on “Download publication”

Combination of Recombinant Human Erythropoietin with Iron Preparation (III) for Intravenous Administration in Oncohematology (Clinical Case)

The clinical observation of treatment of a 59-year-old patient who has been diagnosed with multiple myeloma has been presented. Anemia and iron deficiency are frequent undesirable complications in patients with multiple myeloma and haematological malignancies, including those induced by chemotherapy. The article describes the modern principles of managing patients with ...

The choice of optimal neuroprotective infusion therapy in ischemia/reperfusion in the combination treatment of patients with ischemic stroke in the acute period

Abstract. The objective is to evaluate and compare the dynamics of severity of the patient’s condition and severity of neurological deficit, the state of blood rheology in persons with ischemic stroke against the background of basic therapy with the additional use of neuroprotective infusion therapy and correction of hematoelectrolyte changes ...

Modern look at the treatment of ischemic stroke

1-3th of November, 2018, the IV National Congress “Stroke and Vascular Diseases” was successfully held in Kyiv. Leading specialists from Ukraine, the Czech Republic, Lithuania, Israel and the Republic of South Africa highlighted the current state of the problem of acute cerebral circulation disorder treatment and the main aspects of ...

How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis?

Abstract. Edaravone is a low-molecular-weight antioxidant drug targeting peroxyl radicals among many types of reactive oxygen species. Because of its amphiphilicity, it scavenges both lipid- and water-soluble peroxyl radicals by donating an electron to the radical. Thus, it inhibits the oxidation of lipids by scavenging chain- initiating water-soluble peroxyl radicals ...

CHOICE OF EFFECTIVE ANTIBACTERIALS. WHY FLUOROQUINOLONES?

The aim – to explore the level of resistance to quinolines of nosocomial strains isolated from patients hospitalized in surgical hospitals in different regions of Ukraine.